Related Experiment Video
Updated: May 17, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
A discrete ubiquitin-mediated network regulates the strength of NOD2 signaling
Justine T Tigno-Aranjuez1, Xiaodong Bai, Derek W Abbott
1Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Abstract:
Dysregulation of NOD2 signaling is implicated in the pathology of various inflammatory diseases, including Crohn's disease, asthma, and sarcoidosis, making signaling proteins downstream of NOD2 potential therapeutic targets. Inhibitor-of-apoptosis (IAP) proteins, particularly cIAP1, are essential mediators of NOD2 signaling, and in this work, we describe a molecular mechanism for cIAP1's regulation in the NOD2 signaling pathway. While cIAP1 promotes RIP2's tyrosine phosphorylation and subsequent NOD2 signaling, this positive regulation is countered by another E3 ubiquitin ligase, ITCH, through direct ubiquitination of cIAP1. This ITCH-mediated ubiquitination leads to cIAP1's lysosomal degradation. Pharmacologic inhibition of cIAP1 expression in ITCH(-/-) macrophages attenuates heightened ITCH(-/-) macrophage muramyl dipeptide-induced responses. Transcriptome analysis, combined with pharmacologic inhibition of cIAP1, further defines specific pathways within the NOD2 signaling pathway that are targeted by cIAP1. This information provides genetic signatures that may be useful in repurposing cIAP1-targeted therapies to correct NOD2-hyperactive states and identifies a ubiquitin-regulated signaling network centered on ITCH and cIAP1 that controls the strength of NOD2 signaling.
Insights
NOD2 signaling dysregulation drives inflammatory diseases. This study reveals ITCH E3 ligase targets cIAP1 for degradation, controlling NOD2 pathway strength and offering therapeutic insights.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Signaling
Background:
- NOD2 signaling pathway is crucial in inflammatory diseases like Crohn's disease.
- Inhibitor-of-apoptosis (IAP) proteins, especially cIAP1, are key mediators in NOD2 signaling.
- Dysregulated NOD2 signaling presents therapeutic opportunities targeting downstream proteins.
Purpose of the Study:
- To elucidate the molecular mechanism regulating cIAP1 within the NOD2 signaling pathway.
- To investigate the role of the E3 ubiquitin ligase ITCH in controlling cIAP1 stability.
- To identify therapeutic strategies for hyperactive NOD2 signaling states.
Main Methods:
- Investigated cIAP1 regulation by ITCH in NOD2 signaling.
- Utilized pharmacologic inhibition of cIAP1 in ITCH-deficient macrophages.
- Performed transcriptome analysis to identify targeted pathways.
Main Results:
- cIAP1 promotes RIP2 phosphorylation and NOD2 signaling.
- ITCH ubiquitinates cIAP1, leading to its lysosomal degradation, thus attenuating NOD2 signaling.
- Pharmacologic cIAP1 inhibition reduced inflammatory responses in ITCH-deficient macrophages.
- Transcriptome analysis defined cIAP1-targeted pathways within NOD2 signaling.
Conclusions:
- A ubiquitin-regulated network involving ITCH and cIAP1 controls NOD2 signaling strength.
- cIAP1 is a critical regulator of NOD2-mediated inflammatory responses.
- Findings suggest repurposing cIAP1-targeted therapies for inflammatory diseases with hyperactive NOD2 signaling.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

